FI891820A0 - Biologiskt aktiva foereningar. - Google Patents

Biologiskt aktiva foereningar.

Info

Publication number
FI891820A0
FI891820A0 FI891820A FI891820A FI891820A0 FI 891820 A0 FI891820 A0 FI 891820A0 FI 891820 A FI891820 A FI 891820A FI 891820 A FI891820 A FI 891820A FI 891820 A0 FI891820 A0 FI 891820A0
Authority
FI
Finland
Prior art keywords
biologically active
active foundation
foundation
biologically
active
Prior art date
Application number
FI891820A
Other languages
English (en)
Other versions
FI891820A (fi
Inventor
Robert John Ife
David Gwyn Cooper
Robert Anthony Slater
Karlheinz Stegmeier
Ernst-Christian Witte
Original Assignee
Smith Kline French Lab
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878719717A external-priority patent/GB8719717D0/en
Priority claimed from GB878725540A external-priority patent/GB8725540D0/en
Application filed by Smith Kline French Lab, Boehringer Mannheim Gmbh filed Critical Smith Kline French Lab
Publication of FI891820A0 publication Critical patent/FI891820A0/fi
Publication of FI891820A publication Critical patent/FI891820A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI891820A 1987-08-20 1989-04-17 Biologiskt aktiva foereningar. FI891820A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878719717A GB8719717D0 (en) 1987-08-20 1987-08-20 Pharmaceutically active compounds
GB878725540A GB8725540D0 (en) 1987-10-30 1987-10-30 Pharmaceutically active compounds
PCT/GB1988/000674 WO1989001330A2 (en) 1987-08-20 1988-08-16 W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases

Publications (2)

Publication Number Publication Date
FI891820A0 true FI891820A0 (fi) 1989-04-17
FI891820A FI891820A (fi) 1989-04-17

Family

ID=26292628

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891820A FI891820A (fi) 1987-08-20 1989-04-17 Biologiskt aktiva foereningar.

Country Status (10)

Country Link
US (1) US4997847A (fi)
EP (1) EP0304271A3 (fi)
JP (1) JPH02501142A (fi)
KR (1) KR890701095A (fi)
CA (1) CA1331465C (fi)
DK (1) DK191089D0 (fi)
FI (1) FI891820A (fi)
HU (1) HU208113B (fi)
PT (1) PT88288B (fi)
WO (1) WO1989001330A2 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5153214A (en) * 1989-06-28 1992-10-06 Ciba-Geigy Corporation Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5025025A (en) * 1989-06-28 1991-06-18 Ciba-Geigy Corporation (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
IL94805A (en) * 1989-06-28 1994-04-12 Ciba Geigy Ag Certain translocated carboxylic acids (a) Arylsulfonamide - and pyridyl - or imidazolil (), process for their preparation and pharmaceutical preparations containing them
US5474766A (en) * 1992-12-18 1995-12-12 Washington University Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
IL115833A (en) * 1994-11-25 1998-10-27 Zeneca Ltd Acids 6, 6 - Dihalo - 3, 3 - Dimethyl - 5 - Hydroxy - 7, 7, 7 Triplooroheptanoics and their alkaline esters useful as an intermediate product Insecticides
GB2295389B (en) * 1994-11-25 1998-01-21 Zeneca Ltd Halogenated acids and esters useful as intermediates for insecticides
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666779A (en) * 1967-07-15 1972-05-30 Hoechst Ag Sulfonamido carboxylic acids
DE1298672B (de) * 1967-07-15 1969-07-03 Hoechst Ag Korrosionsverhinderndes Metallbearbeitungsmittel
JPS57314B2 (fi) * 1974-04-10 1982-01-06
JPS5829784B2 (ja) * 1975-08-22 1983-06-24 萬有製薬株式会社 オメガ − （ アリ−ルスルホンアミド ）− アルキルアミンノ セイホウ
DE3266360D1 (en) * 1981-06-16 1985-10-24 Choay Sa Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation

Also Published As

Publication number Publication date
HU884709D0 (en) 1990-02-28
PT88288A (pt) 1989-09-14
PT88288B (pt) 1995-03-31
DK191089A (da) 1989-04-19
DK191089D0 (da) 1989-04-19
US4997847A (en) 1991-03-05
CA1331465C (en) 1994-08-16
KR890701095A (ko) 1989-12-19
EP0304271A2 (en) 1989-02-22
WO1989001330A2 (en) 1989-02-23
HU208113B (en) 1993-08-30
FI891820A (fi) 1989-04-17
EP0304271A3 (en) 1992-09-02
JPH02501142A (ja) 1990-04-19
WO1989001330A3 (en) 1989-05-05

Similar Documents

Publication Publication Date Title
DE3881838D1 (de) Erdbauwerke.
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
ATE73338T1 (de) Biologisch wirksame kopolymere.
FI882407A0 (fi) Fibrinolytiska proteiner.
IT8820550A0 (it) Benzammidi sostituite farmacologicamente attive.
FI875217A (fi) Aktivt pansar.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
FI891820A0 (fi) Biologiskt aktiva foereningar.
IT8920405A0 (it) Aminoimidazopiridine farmacologicamente attive.
FI922720A0 (fi) Farmakologiskt aktiva amidkarboxylatderivat.
FI841649A (fi) Biologiskt aktiva polypeptider.
FI883254A0 (fi) Cytostatiskt aktiva antracyklinderivat.
FI883253A0 (fi) Cytostatiskt aktiva antracyklinderivat.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
FI882071A (fi) Foerhindrande av slambildning.
DE3787371D1 (de) Biologisch aktives mittel.
IT1229230B (it) Piperidinilimidazopiridine farmacologicamente attive.
FI903559A0 (fi) Faestanordning foer baerhandtag.
IT8521449A0 (it) Eterocicli azotati biologicamente attivi.
FI865365A (fi) Biologiska aktiva kopolymerer.
FI860908A0 (fi) Faellanordning foer skogshuggare.
ATE32712T1 (de) Biologisch wirksame amid-derivate.
IT8520726A0 (it) Propionilanilidi farmacologicamente attive.
DK661888D0 (da) Biologisk aktive molekyler
IT8123032A0 (it) Idrazinocefem derivato biologicamente attivo.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BOEHRINGER MANNHEIM GMBH

Owner name: SMITH KLINE & FRENCH LABORATORIES